Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Vaxil Bio Ltd V.VXL

Alternate Symbol(s):  VXLLF

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19... see more

TSXV:VXL - Post Discussion

Vaxil Bio Ltd > Brazil to produce 30M doses of promising experimental corona
View:
Post by bligicka on Jun 28, 2020 6:31am

Brazil to produce 30M doses of promising experimental corona

Brazil to produce 30M doses of promising experimental coronavirus vaccine......BRASILIA, BRAZIL -- The Brazilian government announced on Saturday an agreement with Oxford University and pharmaceutical company AstraZeneca to produce a promising coronavirus vaccine that is undergoing tests. Brazilian Health Ministry authorities said at a news conference that the country will pay $127 million and receive material to produce 30.4 million doses in two batches in December and January, which would allow it to quickly start inoculation efforts if the vaccine is certified to be safe and effective.
Comment by bligicka on Jun 28, 2020 6:38am
BRASILIA, BRAZIL -- The Brazilian government announced on Saturday an agreement with Oxford University and pharmaceutical company AstraZeneca to produce a promising coronavirus vaccine that is undergoing tests. Brazilian Health Ministry authorities said at a news conference that the country will pay $127 million and receive material to produce 30.4 million doses in two batches in December and ...more  
Comment by Valuehunter72 on Jun 28, 2020 8:23am
The Vaxil horse has not even left the stable to get on the track, meanwhile Astra Zeneca is inking these kinds of deals. One of the first 28 horses to show up for the race. Management did not partner up with a major and chose to do all work in house with their small staff. A decision that might cost them from not even showing up for the race before it's over.
Comment by bligicka on Jun 28, 2020 8:52am
Agree 100% Goren needs to be held accountable for this mess of pp ....and what happened to a validated second experiment ???
Comment by kevlin139 on Jun 28, 2020 9:29am
and what are the long term affects to this vaccine????  You cant rush something that you have no long term study
Comment by threefiftynine on Jun 28, 2020 9:39am
Thanks for that kevlin139---and I agree but maybe time for the ceo to step up to the plate and back up your theory by buying some shares---that would be a good sign going forward-----and thanks to the ceo.ca poster who posted a good link ---nice to see away from childish bickering------Some of the key players profiled in the Coronavirus Vaccine Market include Inovio Pharmaceuticals, Inc., Moderna, ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities